Adrenocortical carcinoma (ACC) is an uncommon aggressive endocrine malignancy that is
nonetheless associated with significant mortality and morbidity rates because of endocrine …

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable
prognosis. Here we summarize the knowledge about diagnosis, epidemiology …

Two different primary malignancies can arise from the adrenal gland: adrenocortical
carcinoma (ACC) from the adrenal cortex and malignant phaeochromocytoma from the …

We describe a comprehensive genomic characterization of adrenocortical carcinoma (ACC).
Using this dataset, we expand the catalogue of known ACC driver genes to include …

Importance Adrenalectomy is the definitive treatment for multiple adrenal abnormalities.
Advances in technology and genomics and an improved understanding of adrenal …

Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …

Background Adrenocortical carcinoma is a rare, aggressive cancer for which few treatment
options are available. Linsitinib (OSI-906) is a potent, oral small molecule inhibitor of both …

Adrenocortical carcinoma is a rare heterogeneous neoplasm with an incompletely
understood pathogenesis and a poor prognosis. Previous studies have identified …

Background The clinical course of advanced adrenocortical carcinoma (ACC) is
heterogeneous. Our study aimed primarily to refine and make headway in the prognostic …

Objective Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis.
Herein, we describe the clinical features and outcomes for a large series of ACC patients …